搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Marinobacter aquaeolei Probable chorismate--pyruvate lyase (ubiC) CSB-YP378248MNI
CSB-EP378248MNI
CSB-BP378248MNI
CSB-MP378248MNI
CSB-EP378248MNI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Marinobacter aquaeolei tRNA 2-selenouridine synthase (selU) CSB-YP378249MNI
CSB-EP378249MNI
CSB-BP378249MNI
CSB-MP378249MNI
CSB-EP378249MNI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Marinobacter aquaeolei tRNA sulfurtransferase (thiI) CSB-YP378250MNI
CSB-EP378250MNI
CSB-BP378250MNI
CSB-MP378250MNI
CSB-EP378250MNI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Marinobacter aquaeolei Phosphoenolpyruvate carboxykinase [ATP] (pckA), partial CSB-YP378251MNI
CSB-EP378251MNI
CSB-BP378251MNI
CSB-MP378251MNI
CSB-EP378251MNI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Marinobacter aquaeolei Aspartate carbamoyltransferase (pyrB) CSB-YP378252MNI
CSB-EP378252MNI
CSB-BP378252MNI
CSB-MP378252MNI
CSB-EP378252MNI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Marinobacter aquaeolei Zinc import ATP-binding protein ZnuC (znuC) CSB-YP378253MNI
CSB-EP378253MNI
CSB-BP378253MNI
CSB-MP378253MNI
CSB-EP378253MNI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Marinobacter aquaeolei Aliphatic amidase (amiE) CSB-YP378254MNI
CSB-EP378254MNI
CSB-BP378254MNI
CSB-MP378254MNI
CSB-EP378254MNI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Marinobacter aquaeolei Na (+)/H (+) antiporter nhaB, partial CSB-YP378255MNI
CSB-EP378255MNI
CSB-BP378255MNI
CSB-MP378255MNI
CSB-EP378255MNI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Marinobacter aquaeolei Ribosomal RNA small subunit methyltransferase G (rsmG) CSB-YP378256MNI
CSB-EP378256MNI
CSB-BP378256MNI
CSB-MP378256MNI
CSB-EP378256MNI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Marinobacter aquaeolei tRNA modification GTPase MnmE (mnmE) CSB-YP378257MNI
CSB-EP378257MNI
CSB-BP378257MNI
CSB-MP378257MNI
CSB-EP378257MNI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Marinobacter aquaeolei Membrane protein insertase YidC (yidC), partial CSB-YP378258MNI1
CSB-EP378258MNI1
CSB-BP378258MNI1
CSB-MP378258MNI1
CSB-EP378258MNI1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Marinobacter aquaeolei Ribonuclease P protein component (rnpA) CSB-YP378259MNI
CSB-EP378259MNI
CSB-BP378259MNI
CSB-MP378259MNI
CSB-EP378259MNI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium sp. Ribosomal RNA small subunit methyltransferase G (rsmG) CSB-YP378260MOM
CSB-EP378260MOM
CSB-BP378260MOM
CSB-MP378260MOM
CSB-EP378260MOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium sp. Chromosomal replication initiator protein DnaA (dnaA) CSB-YP378261MOM
CSB-EP378261MOM
CSB-BP378261MOM
CSB-MP378261MOM
CSB-EP378261MOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium sp. UPF0233 membrane protein Mkms_0020 (Mkms_0020), partial CSB-YP378262MOM1
CSB-EP378262MOM1
CSB-BP378262MOM1
CSB-MP378262MOM1
CSB-EP378262MOM1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium sp. Putative S-adenosyl-L-methionine-dependent methyltransferase Mkms_0098 (Mkms_0098) CSB-YP378263MOM
CSB-EP378263MOM
CSB-BP378263MOM
CSB-MP378263MOM
CSB-EP378263MOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium sp. Putative S-adenosyl-L-methionine-dependent methyltransferase Mkms_0379 (Mkms_0379) CSB-YP378264MOM
CSB-EP378264MOM
CSB-BP378264MOM
CSB-MP378264MOM
CSB-EP378264MOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium sp. Deoxycytidine triphosphate deaminase (dcd) CSB-YP378265MOM
CSB-EP378265MOM
CSB-BP378265MOM
CSB-MP378265MOM
CSB-EP378265MOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium sp. Na (+)/H (+) antiporter nhaA 1, partial CSB-YP378266MOM
CSB-EP378266MOM
CSB-BP378266MOM
CSB-MP378266MOM
CSB-EP378266MOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium sp. Acetate kinase (ackA) CSB-YP378267MOM
CSB-EP378267MOM
CSB-BP378267MOM
CSB-MP378267MOM
CSB-EP378267MOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>